Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Congo's Ebola outbreak reaches 5,000 cases as it outpaces response efforts at unprecedented speed

The Ebola outbreak in Congo has reached 5,000 cases, government data showed Wednesday, as responders warn it is spreading at an unprecedented speed outpacing efforts to slow it in one of the country's remotest regions.

Congo's Ebola outbreak reaches 5,000 cases as it outpaces response efforts at unprecedented speed

The Ebola outbreak in Congo has reached 5,021 cases with 2,378 deaths, representing a fatality rate of 47.4%, according to government data as of Sunday. This outbreak is spreading at an unprecedented speed and outpacing response efforts in one of the country's most remote regions. The World Health Organization (WHO) estimates that this outbreak could surpass the deadliest Ebola outbreak on record in West Africa from 2014 to 2016, which claimed over 11,000 lives.

The current outbreak is spreading about three times faster than the 2014-2016 outbreak. WHO Director-General Tedros Adhanom Ghebreyesus warned that the epidemic is far from being under control during a recent meeting. The outbreak has been fueled by insecurity, displacement, and intense population movements, making it difficult for health workers to reach those in need.

Thérèse Anyiya, a nurse in Ituri's capital Bunia, expressed exhaustion due to the demanding work conditions and inadequate pay. Some health workers have even gone on strike. The primary challenge has been the lack of approved vaccines or treatments for the Bundibugyo virus, the cause of the current outbreak. Most new cases are being reported outside of the monitored areas, indicating rapid spread and challenges for surveillance teams.

The Ituri province, hit the worst by the outbreak, has become a hotspot for violence, with health workers targeted by residents. The response efforts are hampered by limited access to care, threats from rebel groups, angry communities traumatized for years, and poor road infrastructure. While the case fatality rate in Ituri is 47.4%, it is as high as 70% in North Kivu province, where response efforts are more challenging. No approved vaccines or treatments are currently available for this rare virus.

Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at medicalxpress.com →

More in Health & Medicine

Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial

Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly.

  • Moderna's shares surged 135% to $148.02 after cancer vaccine trial success
  • Intismeran vaccine combined with Merck's Keytruda showed reduced melanoma recurrence
  • Merck's shares rose 11% to $150.14, indicating potential growth for both companies

More from Wednesday 19 August →